Nanobodies: their potential for applications in biotechnology, diagnosis and antiviral properties in Africa; focus on application in agriculture-Reference-Cited by-同舟云学术

Nanobodies: their potential for applications in biotechnology, diagnosis and antiviral properties in Africa; focus on application in agriculture

Published:2021-01-01 Issue:1 Volume:35 Page:1331-1342
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Njeru Faith Njeri¹^ORCID,Kusolwa Paul Mbogo²

Affiliation:

1. Department of Veterinary Microbiology, Parasitology and Biotechnology, Southern African Centre for Infectious Disease Surveillance (SACIDS), Sokoine University of Agriculture, Morogoro, Tanzania

2. Department of Crop Science and Horticulture, College of Agriculture, Sokoine University of Agriculture, Morogoro, Tanzania

Publisher

Informa UK Limited

Subject

Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13102818.2021.1974943

Reference54 articles.

1. JANEWAY'S IMMUNOBIOLOGY, 7TH EDITION

2. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. The Generation of Antibody Diversity. Available from: https://www.ncbi.nlm.nih.gov/books/NBK26860/.

3. Engineered antibody fragments and the rise of single domains

4. Stable recombinant alpaca antibodies for detection of Tulip virus X

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production of nanobodies in Andean camelids and their most common applications: A general review in the medical field.;Bionatura;2023-06-15

2. Structural Modeling of Nanobodies: A Benchmark of State-of-the-Art Artificial Intelligence Programs;Molecules;2023-05-09

3. Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme;Frontiers in Bioengineering and Biotechnology;2022-12-23

4. Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme;2022-09-03